Serum IFN neutralizing antibodies and neopterin levels in a cross-section of MS patients

Abstract

NAb are more commonly found with Betaseron than Avonex. More studies are needed to determine the correlation among serum neopterin levels, other biologic response markers, NAb, and disease activity in patients with MS being treated with IFNbeta.

References

Page 1

	Year	Citations
PRISMS-4: Long-term efficacy of interferon-β-1a in relapsing MS Neurology	2001	566
PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS G. Francis, Richard AC Hughes, John King, DIAL (Catholic University of Leuven)	2001	472
Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b Neurology Neurological DisorderIfnb NabImmunologyBrain LesionImmune System	1996	360
Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis R. A. Rudick, Nancy A. Simonian, Jehan Alam, Neurology	1998	331
Resistance to Recombinant Interferon Alfa-2a in Hairy-Cell Leukemia Associated with Neutralizing Anti-Interferon Antibodies Ronald G. Steis, John W. Smith, Walter J. Urba, New England Journal of Medicine ImmunohematologyMixed-phenotype Acute LeukemiaImmunodeficienciesImmunologyPathology	1988	246
Immunogenicity of interferon-? in multiple sclerosis patients: Influence of preparation, dosage, dose frequency, and route of administration Katja Maria Clemmesen, Morten Svenson, P. S. S�rensen, Annals of Neurology ImmunodeficienciesImmunologyImmunotherapyMultiple Sclerosis PatientsIfnbeta Species	2000	224
Bioavailability of interferon beta 1b in MS patients with and without neutralizing antibodies Florian Deisenhammer, Markus Reindl, Jennifer Harvey, Neurology	1999	196
Recombinant human interferon (IFN) alpha‐2b in chronic myelogenous leukaemia: dose dependency of response and frequency of neutralizing anti‐interferon antibodies Mathias Freund, Peter von Wussow, H. Diedrich, British Journal of Haematology	1989	109
Comparative Study of the Pharmacodynamic and Pharmacologic Effects of Betaseron <sup>®</sup> and AVONEX <sup>™</sup> Gary J. Williams, Patricia L. Witt Journal of Interferon & Cytokine Research	1998	91
A comparative study of the relative bioavailability of different interferon beta preparations Florian Deisenhammer, Irmgard Mayringer, Jennifer Harvey, Neurology	2000	85

Page 1